The Cannabis Investor Series Ep 4: The Global Cannabis Economy | Presented by CSE
The Cannabis Investor Series Ep 4: The Global Cannabis Economy | Presented by CSE
The legalization of cannabis is truly a global movement. In this session, our speakers will look beyond Canada and the US, and explore what’s happening around the world. Topics will include medical cannabis in Europe and Israel, cultivation in Mexico and across Latin America, and recent developments in Asia:
Media Sponsor: Prohibition Partners
Scroll down to see our incredible lineup of speakers for this episode:
Hosted by:
Barrington Miller – CSE – Canadian Securities Exchange
Anna Serin – CSE – Canadian Securities Exchange
0:00 – Intro
0:44 – Introducing Episode 4 of the Cannabis Investor Series
6:07 – An Intro to Latin America – Hector Gomes de Sousa, Research Analyst – Prohibition Partners
8:09 – Part 1 – An Update on LATAM moderated by Javier Hasse, Managing Director – Benzinga Cannabis
9:00 – Alfredo Pascual, VP of Investment Analysis – FastForward Innovations Ltd. (LON:FFWD)
10:31 – Emily Paxhia, Managing Director Poseidon Asset Management, LLC
30:55 – Aras Azadian, CEO – Avicanna Inc.
37:16 – Jose Forero, Country Manager – Presidente – Blueberries Medical Corp. (CSE:BBM)
41:46 – Part 2 – Mexico and the Road to Legalization moderated by Anna Serin – CSE – Canadian Securities Exchange
43:01 – Luis Armendariz, Global Practice Area Leader – Hoban Law Group
45:21 – Lorena Beltran, Founder & Director – CannabiSalud
48:48 – Ralph Schulke, CEO – Innerbloom Holdings S.A.P.I.
1:06:41 – Steve DeAngelo, Father of the Legal Cannabis Industry
1:23:25 – An Intro to Europe – Conor O’Brien, Analyst – Prohibition Partners
1:25:03 – Part 3 – Europe & Israel moderated by Patricia Nilsson, Reporter – Financial Times
1:25:18 – Boris Jordan, Executive Chairman – Curaleaf Holdings, Inc. (CSE:CURA)
1:35:16 – Oren Shuster, CEO -IM Cannabis Corp. (CSE:IMCC)
1:39:41 – Intro to Asia – Conor O’Brien, Analyst – Prohibition Partners
1:41:14 – Part 4 – Asia & Australia hosted by Phillip Shum, CSE – Canadian Securities Exchange
1:41:45 – Philip Gu, CEO – CEO at Stemcell United Limited (ASX:SCU)
1:51:44 – Tom Kruesopon, Founder – Golden Triangle Health Company Ltd.
2:03:03 – Intro to Australia – Conor O’Brien, Analyst – Prohibition Partners
2:04:49 – Matt Cantelo, CEO – Australian Natural Therapeutics Group (ANTG)
2:15:23 – Series wrap with Barrington and Anna
About the Cannabis Investor Series
Join us to hear from trailblazing experts and influencers who are shaping this rapidly-evolving industry, and gain insights into the opportunities and challenges ahead as global acceptance of cannabis continues to rise.
🔴 Subscribe for more great CSE insights and interviews here: https://bit.ly/CSETVSubscribe
STAY CONNECTED WITH THE CSE
=============================
🎧 – PODCAST: https://blog.thecse.com/pe-podcasts/
📸 – INSTAGRAM: https://www.instagram.com/canadianexchange/
🤝 – LINKEDIN: https://ca.linkedin.com/company/canadian-securities-exchange
👥 – FACEBOOK: https://www.facebook.com/CanadianSecuritiesExchange/
🐦 – TWITTER: https://twitter.com/CSE_News
📝 – BLOG: https://blog.thecse.com/
🖥 – WEBSITE: https://thecse.com/
